Filing Details

Accession Number:
0000899243-21-044648
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-15 18:52:09
Reporting Period:
2021-11-15
Accepted Time:
2021-11-15 18:52:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1851657 Vaxxinity Inc. VAXX Pharmaceutical Preparations (2834) 862083865
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1890672 Ulo Palm C/O Vaxxinity, Inc.
1717 Main St, Ste 3388
Dallas TX 75201
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-11-15 450 $13.00 450 No 4 P Indirect Held by spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock option (right to buy) Acquisiton 2021-11-11 233,100 $0.00 233,100 $13.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
233,100 2031-11-11 No 4 A Direct
Footnotes
  1. These securities were purchased through the Issuer's directed share program in connection with its initial public offering.
  2. These securities are held by Kathrin Palm, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kathrin Palm in which the Reporting Person has no pecuniary interest.
  3. These options are subject to a four-year time-vesting schedule, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal installments each month during the remainder of the vesting period.